Five Concurrent Infections in a Kidney Transplant Recipient Receiving Belatacept (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1124; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Induction included ATG and steroids, followed by tacrolimus, MMF, and prednisone. On postoperative day 3, the patient developed thrombotic microangiopathy, prompting tacrolimus discontinuation and transition to cyclosporine...Infectious workup demonstrated Cytomegalovirus infection (1040 IU/mL), treated with ganciclovir, and blood cultures grew Pseudomonas aeruginosa infection...The clustering of multiple opportunistic and severe infections in a single patient highlights the profound immunomodulatory effects of belatacept, particularly in individuals with prior intensive immunosuppression. To our knowledge, this represents a uniquely complex case report demonstrating simultaneous multi-pathogen infection in the setting of belatacept"
Clinical • Chronic Kidney Disease • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Glomerulonephritis • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Transplantation
|
|
Saad Abdulrahim Talal Mahmoud; Abinay Siva kumar Reddy Vanteru; Avantika Israni
|